GGrantIndex
Sort

51,593 grants matching hepatitis

RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression

$726,498
Carl A Latkin · Johns Hopkins University · R01 · FY2020 · DA

VLP Vaccine Technology

$726,333
Sang-Moo Kang · Georgia State University · R01 · FY2014 · AI

VLP Vaccine Technology

$726,333
Sang-Moo Kang · Georgia State University · R01 · FY2016 · AI

VLP Vaccine Technology

$726,333
Sang-Moo Kang · Georgia State University · R01 · FY2017 · AI

VLP Vaccine Technology

$726,333
Sang-Moo Kang · Georgia State University · R01 · FY2015 · AI

HIV HCV Coinfection Antiviral Therapy and Fibrosis

$726,240
David L Thomas · Johns Hopkins University · R37 · FY2016 · DA

Vascular Targeting of Nanocarriers for RNA

$726,234
Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2021 · HL

NanoDisk-Amphotericin B therapy for aspergillosis

$726,199
Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2010 · AI

Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction

$726,132
John Blangero · University Of Texas Rio Grande Valley · R01 · FY2022 · MD

MDCT Quantification of hepatic tumor viability for assessment of cancer therapy

$726,042
Yin Wu · Iq Medical Imaging, Llc · R42 · FY2018 · CA

Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes

$726,033
David C. Johnson · Oregon Health & Science University · R01 · FY2024 · AI

HBV-specific T cell immunity in HBV/HIV coinfection

$725,950
Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R37 · FY2024 · AI

Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection

$725,925
Neel Rajnikant Gandhi · Emory University · R01 · FY2018 · AI

Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy

$725,922
Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · R24 · FY2017 · OD

Role of PXR in drug-elicited cardiovascular disease

$725,876
Changcheng Zhou · University Of California Riverside · R01 · FY2023 · HL

Oxytocin as a Neuroendocrine Therapy for Obesity in Youth

$725,838
Elizabeth Austen Lawson · Massachusetts General Hospital · R01 · FY2021 · DK

Descriptive Studies and Record Linkage

$725,750
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

Discovery and Assessment of Genetic Determinants of HCV and HIV Control

$725,722
Raymond T Chung · Massachusetts General Hospital · R01 · FY2011 · DA

A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland

$725,533
Carl A Latkin · Johns Hopkins University · R01 · FY2025 · DA

Clinical Research Resources and Facilities

$725,528
Judith E Feinberg · West Virginia University · U54 · FY2019 · GM

Collagen fibers and fragments regulate pancreatic cancer metabolism and growth.

$725,478
Michael Karin · University Of California, San Diego · R01 · FY2024 · CA

Phase I Trials of Anti-Cancer Agents

$725,427
Michael R Grever · Ohio State University · U01 · FY2008 · CA

Natural model for evaluating within- and cross-species virus transmission

$725,409
Ryan Langlois · University Of Minnesota · R01 · FY2024 · AI

NATURAL HISTORY OF HIV INFECTION IN WOMEN

$725,390
Montefiore Medical Center (Bronx, Ny) · U01 · FY2003 · AI

Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway

$725,348
Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2021 · DK